Ruth Arnon
Ruth Arnon | |
---|---|
Robert Koch Prize (1979), Wolf Prize in Medicine (1998) | |
Scientific career | |
Fields | Immunology, Virology |
Institutions | Weizmann Institute of Science |
Doctoral advisor | Michael Sela |
Ruth Arnon (
Biography
Ruth Rosenberg (later Arnon) was born in Tel Aviv, the youngest of three children.[1] Her father, Alexander Rosenberg, moved with the family to Toulouse to pursue degrees in electrical engineering and mathematics. Upon their return to Israel, he worked for the Israel Electric Corporation. Arnon says her interest in science was inspired by her father. She attended Herzliya Hebrew Gymnasium and knew she wanted to be a medical researcher by the age of 15. She studied chemistry at the Hebrew University of Jerusalem before joining the Israel Defense Forces's Atuda academic study program. Arnon earned her M.Sc. degree in 1955 and served for two years as an officer in the IDF. During her time in the military, she married Uriel Arnon, an engineer at the Technion in Haifa. They have two children: Michal (b. 1957) and Yoram (b. 1961).[2]
Scientific career
Arnon joined the
Arnon served as the Chairperson of the Sciences division of the Israel Academy of Sciences from 1995 to 2001. She later was elected as President of the Israel Academy. She is also a member of the EMBO, the European Molecular Biology Organization. Arnon served as Secretary-General of the International Union of Immunological Sciences, the President of the European Federation of Immunological Societies, and is also a member of the European Union Research Advisory Board.
Arnon has published more than four hundred articles in biochemistry and immunology.
She was a visiting professor at the Rockefeller Institute (New York), University of Washington (Seattle), University of California (Los Angeles), Pasteur Institute (Paris), Walter and Elise Hall Institute (Melbourne), Imperial Cancer Research Fund (London), and the Curie Institute (Paris).
Copaxone
Arnon and Sela developed a new drug application for the treatment of
Current Research
Arnon is researching a universal, recombinant influenza vaccination, as well as a cancer vaccine. A 2009 paper discusses the use of
In 2017 Arnon was appointed co-chair of the UK-Israel Science Council, alongside
Summary Ruth Rosenberg (later Arnon) was the youngest of three children born in Tel Aviv. [1] Alexander Rosenberg, her father, travelled to Toulouse with his family to pursue degrees in electrical engineering and mathematics. He went to work for the Israel Electric Corporation after they returned to Israel. Her father, according to Arnon, sparked her interest in science. Arnon's work has mostly focused on the creation of vaccines and cancer studies. Working on the development of Copaxone, a medication for multiple sclerosis, with Professor Michael Sela was one of her most significant contributions to science. Copaxone's development began with the successful creation of the first synthetic antigen. They discovered that a substance synthesised in the lab might inhibit a condition observed in animals which is a paradigm for multiple sclerosis, along with Devorah Tietelbaum, who was a doctorate student at the time. Copaxone was licensed for medical use after thirty years of research. Copolymer 1 is a novel medication application created by Arnon and Sela for the treatment of multiple sclerosis. Glatiramer acetate is its chemical name. On June 14, 1995, the TEVA Pharmaceutical Company submitted it to the FDA for approval under the name Copaxone. Cop 1 is an immunospecific medication, which makes sense given that multiple sclerosis is an immunological illness. Arnon has spent the majority of her career working in the field of immunology. It promotes neuroprotection and generation while also preventing axon demyelination, which is a characteristic of illnesses like multiple sclerosis. In fact, research by Arnon et al. have found that Cop 1 causes an increase in myelination. Currently, Arnon is working on a recombinant influenza vaccine that is universal as well as a cancer vaccine. The use of virus-like particles (VLP) to generate an immune response was discussed in a 2009 research. She has won 12 awards and recognitions in her career.
Awards and recognition
- 1979 - Robert Koch Prize in Medical Sciences, Germany[10]
- 1986 - Jimenez Diaz Award, Spain
- 1990 - Elected Member of the Israel Academy of Sciences and Humanities
- 1991 - Hadassah Women of Distinction Award
- 1994 - Chevalier de l'Ordre de la Légion d'Honneur, France
- 1998 - Copaxone
- 1998 - Rothschild Prize in Life Sciences[11]
- 2001 - Israel Prize in medicine[12]
- 2009 - Elected member of the American Philosophical Society[13]
- 2010 - First female president of the Israel Academy of Sciences and Humanities
- 2020 - OurCrowd Maimonides Award for Lifetime Achievement in Science, Leadership and Menschlichkeit[14]
- 2021 - Honorary Officer of the Order of the British Empire (OBE)[15]
See also
- Women of Israel
References
- ^ Could the flu become history? An Israeli vaccine may do just that, Haaretz
- ^ Ruth Arnon, Jewish Women's Archives
- ^ Ruth Arnon, Jewish Women's Archives
- PMID 8793553.
- S2CID 53189444.
- PMID 15371592.
- PMID 19492960.
- ^ Prof. Ruth Arnon. Weizmann Institute of Science: Department of Immunology [Internet]. [cited 15 Apr 2015]; Available from http://www.weizmann.ac.il/immunology/sci/ArnonPage.html
- ^ "UK-Israel Science Council | British Council". www.britishcouncil.org.il. Retrieved 2017-07-24.
- ^ Ruth Arnon, Jewish Women's Archives
- ^ "Official site of the Rothschild Prize". Archived from the original on 2016-03-13. Retrieved 2013-10-17.
- ^ The Gale Group. 2008. Professor Ruth Arnon. [Internet]. Weizmann Institute of Science, Department of Immunology; [cited 13 Apr 2015]
- ^ "APS Member History". search.amphilsoc.org. Retrieved 2019-04-07.
- ^ "86-year-old Copaxone creator has no intention of slowing down". Retrieved 2020-02-16.
- ^ "Honorary Awards to Foreign Nationals in 2021". Gov.UK. 2021.